75 related articles for article (PubMed ID: 38651138)
1. Severe Mpox Among People With Advanced Human Immunodeficiency Virus Receiving Prolonged Tecovirimat in New York City.
Garcia EA; Foote MMK; McPherson TD; Lash MK; Bosompem AN; Bouscaren A; Chan J; DiLorenzo MA; Feihel D; Fowler RC; Gandhi V; Jenny-Avital ER; Kopping EJ; Mazo D; McLean J; Mgbako O; Sayegh MN; Shaw RN; Su M; Meissner JS; Wang JC; Wen W; Winters JC; Zeana CB; Zucker J; Wong M
Open Forum Infect Dis; 2024 Jun; 11(6):ofae294. PubMed ID: 38868307
[TBL] [Abstract][Full Text] [Related]
2. A Prolonged Case of Severe Mpox as an Opportunistic Infection in Advanced AIDS.
Malka MS; Parkinson M; Zucker J; McLean JR; Pereira MR; Yin MT; Gunaratne SH
Cureus; 2024 May; 16(5):e59947. PubMed ID: 38854169
[TBL] [Abstract][Full Text] [Related]
3. Ocular manifestations of mpox.
Nguyen M; Doan T; Seitzman GD
Curr Opin Ophthalmol; 2024 Jun; ():. PubMed ID: 38847744
[TBL] [Abstract][Full Text] [Related]
4. Successful Distribution of Tecovirimat During the Peak of the Mpox Outbreak - Los Angeles County, June 2022-January 2023.
O'Neil MJ; Archer R; Danza P; Fisher R; Bagwell DA; Younis I; Kulkarni S; Rubin Z; Kim M; Balter S; Terashita D; Kim J; Singhal R; Hancz D; Gausche-Hill M; Shah NK
MMWR Morb Mortal Wkly Rep; 2024 Jun; 73(24):546-550. PubMed ID: 38900699
[TBL] [Abstract][Full Text] [Related]
5. Breaking Barriers: Current Advances and Future Directions in Mpox Therapy.
Shah BM; Modi P
Curr Drug Targets; 2024; 25(1):62-76. PubMed ID: 38151842
[TBL] [Abstract][Full Text] [Related]
6. Severe Presentation of Mpox With Skin, Lung and Pleural Involvement in a Non-HIV Infected Kidney Transplant Recipient.
Colina-García JF; Caso JM; González-García C; Folgueira MD; Hernández AM; Auñón P; Andrés A; Cavero T; López-Medrano F; Morales E
Am J Kidney Dis; 2024 Jun; ():. PubMed ID: 38866126
[TBL] [Abstract][Full Text] [Related]
7. The Sexual Health Clinic Role in Vaccine and Treatment Access During the 2022 Mpox Outbreak in King County, Washington.
Karmarkar EN; Cannon CA; Golden MR; Thibault CS; Zinsli K; Kim J; Pogosjans S; Chow EJ; Herrmann SO; Ocbamichael N; Ramchandani MS; Dombrowski JC
Sex Transm Dis; 2024 Jun; ():. PubMed ID: 38864518
[TBL] [Abstract][Full Text] [Related]
8. Severe mpox requiring colostomy in a patient with advanced HIV disease: a case report and literature review.
Lim SY; Yim HS; Ahn EJ; Chang E; Yoon J; Suh JH; Um J; Kim HS; Kim MK; Kim Y; Kim G; Jeon J; Park JS; Chin B
J Infect Chemother; 2024 Jun; ():. PubMed ID: 38936771
[TBL] [Abstract][Full Text] [Related]
9. Concerns With Analysis in Study of Tecovirimat for Mpox Among People With HIV.
Ting YH; Lee YC; Chang KY
JAMA Intern Med; 2024 Jun; 184(6):706. PubMed ID: 38683592
[No Abstract] [Full Text] [Related]
10. Concerns With Analysis in Study of Tecovirimat for Mpox Among People With HIV-Reply.
Aldred B; Lyles RH; Cantos VD
JAMA Intern Med; 2024 Jun; 184(6):706-707. PubMed ID: 38683580
[No Abstract] [Full Text] [Related]
11. Ocular Mpox in a Breastfeeding Healthcare Provider.
Lovett S; Griffith J; Lehnertz N; Fox T; Siwek G; Barnes AMT; Kofman AD; Hufstetler K; Greninger AL; Townsend MB; Carson WC; Lynfield R; Cash-Goldwasser S
Open Forum Infect Dis; 2024 Jun; 11(6):ofae290. PubMed ID: 38872848
[TBL] [Abstract][Full Text] [Related]
12. Repurposing of the antibiotic nitroxoline for the treatment of mpox.
Bojkova D; Zöller N; Tietgen M; Steinhorst K; Bechtel M; Rothenburger T; Kandler JD; Schneider J; Corman VM; Ciesek S; Rabenau HF; Wass MN; Kippenberger S; Göttig S; Michaelis M; Cinatl J
J Med Virol; 2023 Mar; 95(3):e28652. PubMed ID: 36897017
[TBL] [Abstract][Full Text] [Related]
13. Clinical considerations on monkeypox antiviral medications: An overview.
Pourkarim F; Entezari-Maleki T
Pharmacol Res Perspect; 2024 Feb; 12(1):e01164. PubMed ID: 38149674
[TBL] [Abstract][Full Text] [Related]
14. Emerging pharmacological strategies for treating and preventing mpox.
Grosenbach DW; Russo AT; Blum ED; Hruby DE
Expert Rev Clin Pharmacol; 2023; 16(9):843-854. PubMed ID: 37592723
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological treatment and vaccines in monkeypox virus: a narrative review and bibliometric analysis.
Shamim MA; Satapathy P; Padhi BK; Veeramachaneni SD; Akhtar N; Pradhan A; Agrawal A; Dwivedi P; Mohanty A; Pradhan KB; Kabir R; Rabaan AA; Alotaibi J; Al Ismail ZA; Alsoliabi ZA; Al Fraij A; Sah R; Rodriguez-Morales AJ
Front Pharmacol; 2023; 14():1149909. PubMed ID: 37214444
[TBL] [Abstract][Full Text] [Related]
16. Challenges in Managing Treatment-Resistant Mpox Complicated by Severe Superinfection.
Fortier JC; Marsalisi C; Cordova E; Guo HJ; Verdecia J
Open Forum Infect Dis; 2024 Apr; 11(4):ofae138. PubMed ID: 38651138
[TBL] [Abstract][Full Text] [Related]
17. Successful Outcome after Treatment with Cidofovir, Vaccinia, and Extended Course of Tecovirimat in a Newly-Diagnosed HIV Patient with Severe Mpox: A Case Report.
Martinez AE; Frattaroli P; Vu CA; Paniagua L; Mintz J; Bravo-Gonzalez A; Zamudio P; Barco A; Rampersad A; Lichtenberger P; Gonzales-Zamora JA
Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992234
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
